Platelet–endothelial cell interaction in brain microvessels of angiotensin II type-2 receptor knockout mice following transient bilateral common carotid artery occlusion Takuya FukuokaTakeshi HayashiNorio Tanahashi OriginalPaper 01 August 2015 Pages: 401 - 405
Preferences for anticoagulation therapy in atrial fibrillation: the patients’ view Björn BöttgerInga-Marion Thate-WaschkeThomas Wilke OriginalPaper 11 August 2015 Pages: 406 - 415
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa Pancras C. WongMimi L. QuanDietmar A. Seiffert OriginalPaper 07 August 2015 Pages: 416 - 423
Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism Göktürk İpekMehmet Baran KarataşOsman Bolca OriginalPaper 14 April 2015 Pages: 424 - 429
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves Jacqueline M. SchulmanAmmar MajeedAnna Ågren OriginalPaper 14 April 2015 Pages: 430 - 436
In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices Gaurav GirdharJunwei LiWayne L. Chandler OriginalPaper 15 May 2015 Pages: 437 - 443
Fructose induces prothrombotic phenotype in human endothelial cells Plinio CirilloGrazia PellegrinoBruno Trimarco OriginalPaper 24 June 2015 Pages: 444 - 451
Endovascular infection following inferior vena cava (IVC) filter insertion Amihai RottenstreichRachel Bar-ShalomYosef Kalish OriginalPaper 17 April 2015 Pages: 452 - 457
Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals Bongani B. NkambuleGlenda DavisonHayley Ipp OriginalPaper 22 April 2015 Pages: 458 - 467
Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany Carolin PütterOlga von BeckerathKnut Kröger OriginalPaper 15 August 2015 Pages: 468 - 473
Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis Bethany SamuelsonChatree Chai-AdisaksophaDavid Garcia OriginalPaper 17 April 2015 Pages: 474 - 479
Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement Victor Gurewich ReviewPaper Open access 18 April 2015 Pages: 480 - 487
The changing characteristics of atrial fibrillation patients treated with warfarin Andrew PutnamXiaokui GuGeoffrey D. Barnes OriginalPaper 01 July 2015 Pages: 488 - 493
Body mass index predicts major bleeding risks in patients on warfarin Adedotun A. OgunsuaSunkaru TourayJoel Gore OriginalPaper 16 June 2015 Pages: 494 - 498
Aspirin dosing in cardiovascular disease prevention and management: an update Leila GanjeheiRichard C. Becker ReviewPaper 01 September 2015 Pages: 499 - 511
Consequences of treating false positive heparin-induced thrombocytopenia Jacob MarlerJessica UnzagaCarrie S. Oliphant Letter to the Editor 03 June 2015 Pages: 512 - 514
Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2 Juan DuYan ZhuLin Liu Report 06 August 2015 Pages: 515 - 519
Survival analysis in patients with ischemic stroke Tomoyuki Kawada Letter to the Editor 23 January 2015 Pages: 520 - 520
The contribution of apixaban renal clearance to total clearance Charles FrostRebecca A. Boyd Letter to the Editor Open access 12 May 2015 Pages: 521 - 522
Erratum to: The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers Noa Zemer-WassercugMoti HaimEli I. Lev Erratum 01 September 2015 Pages: 523 - 523